GENEVA, April 22 (Reuters) - Technical experts at the World
Health Organization (WHO) will review on April 26 Chinese
drugmaker Sinopharm's COVID-19 vaccine for possible emergency
use listing, to be followed by the Sinovac jab on May 3,
the agency said on Thursday.
"We would expect a decision a couple of days later," the WHO
said in response to a Reuters query.
So far COVID-19 vaccines made by Pfizer
AstraZeneca and Johnson & Johnson have received
a WHO listing - an endorsement of their safety and efficacy that
helps to guide countries' regulatory agencies.
(Reporting by Stephanie Nebehay
Editing by David Goodman
)
Astrazeneca (AZN)
